Replies to post #94296 on Regen BioPharma Inc (RGBP)

[Bridget21]

"...what would be the most efficient actions to undertake in order to commercialize the Company’s NR2F6 intellectual property as well as assist the Company with regulatory strategy with regard to the Company’s NR2F6 intellectual property..."

RGBP wants to commercialize/regulatory strategy NR2F6.
Is it a good move?
What can we expect next?

[Jaguarjacket]

Strong Foundation - Successful Results
Biotech Research Group is a full service regulatory and product development consulting firm. BRG has an excellent reputation as a leading regulatory and scientific affairs consulting firm, which has clients and consultants in over 60 countries across the globe. The primary aim of BRG is to provide efficient and expeditious services and give the best solutions for our clients’ products that include pharmaceutical consulting, medical devices, healthcare information technology, and scientific services. In addition, BRG is an experienced and knowledgeable Biologics consulting group.

[Jaguarjacket]

The termination date of this Scope of Work Order is November 15, 2021.